Biotech investing, decoded.
AI-powered clinical trial analysis in plain English. Free catalyst calendar, 600+ company profiles, and weekly briefings.
Trial Translator
NEWPaste any ClinicalTrials.gov ID and get an instant, AI-powered analysis in plain English. No jargon. No signup. What the trial means for investors, in seconds.
Try it free →600+
Company profiles
1,200+
Trials analyzed
Daily
Catalyst updates
Free
Core tools
What you get
Everything a biotech investor needs. Free.
We pull data from ClinicalTrials.gov, SEC filings, and FDA databases — then explain what it means for your portfolio.
Catalyst calendar
Every PDUFA date, Phase 3 readout, and FDA meeting — with plain-English explanations.
AI trial analysis
We read the clinical trial data so you don't have to. Plain-English explainers and investor significance scores.
Company profiles
600+ biotech companies with pipelines, bull/bear cases, and financial snapshots.
Biotech screener
Filter by therapeutic area, trial phase, market cap, cash runway, and upcoming catalysts.
Learn biotech
From "what is a PDUFA date" to advanced catalyst trading. Guides for real people.
Weekly briefing
Every Sunday: the biggest biotech catalysts, what they mean, and what to watch. Free.
Explore by area
Therapeutic areas
Dive into the disease areas driving biotech stock movements.
Subscribe
Stay Ahead of the Market
Choose the plan that fits your investing style. Start free, upgrade when you are ready.
Free
$0/month
- Weekly catalyst briefing
- Basic company profiles
- Catalyst calendar access
- Blog articles
Premium
$19/month
- Everything in Free, plus:
- AI-powered trial analysis
- Real-time catalyst alerts
- Advanced biotech screener
- Unlimited Trial Translator
- Premium company deep-dives
Cancel anytime. No credit card required to start.
No spam. No financial advice. Unsubscribe anytime.